FindTrial
Sign In

Association between Metabolic Syndrome and tumor histologic grade and pathologic: a retrospective study based on medical records

Association between Metabolic Syndrome and tumor histologic grade and pathologic: a retrospective study based on medical records

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000041079
Enrollment
Unknown
Registered
2020-12-17
Start date
2020-12-19
Completion date
Unknown
Last updated
2021-03-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

bladder cancer

Interventions

grouped according to histological grade and pathological stage of bladder cancer:Nil

Sponsors

Shandong Provincial Hospital
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
37 Years to 92 Years

Inclusion criteria

Inclusion criteria: 1. Postoperative pathology confirmed that they were all bladder cancer, 2. Meet the (metabolic syndrome) MetS diagnostic criteria; 3. Complete clinical pathological data.

Exclusion criteria

Exclusion criteria: 1. Neoadjuvant radiotherapy and chemotherapy before surgery; 2. Emergency surgery; 3. Tumor metastasis.

Design outcomes

Primary

MeasureTime frame
Pathological grade;—

Countries

China

Contacts

Public ContactGuan Yong

Shandong University

xuzhihesdu@163.com+86 13181742013

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026